DrugPatentWatch Database Preview
Tocilizumab - Biologic Drug Details
Summary for tocilizumab
| Tradenames: | 1 |
| Patents: | 60 |
| Applicants: | 1 |
| BLAs: | 2 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for tocilizumab |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for tocilizumab |
Recent Clinical Trials for tocilizumab
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| German Cancer Research Center | Phase 1 |
| University Hospital Tuebingen | Phase 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1/Phase 2 |
Recent Litigation for tocilizumab
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Celgene Corporation v. Aurobindo Pharma Limited | 2018-07-06 |
| CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD. | 2018-06-28 |
| CELGENE CORPORATION v. SANDOZ INC. | 2018-06-26 |
See all tocilizumab litigation
PTAB Litigation
| Petitioner | Date |
|---|---|
| Crescendo Bioscience, Inc | 2017-04-12 |
Pharmacology for tocilizumab
| Mechanism of Action | Interleukin 6 Receptor Antagonists |
Patent Text Search: US Patents for tocilizumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | ACTEMRA | tocilizumab | INJECTABLE; INJECTION | 125276 | 001 | 2010-01-08 | Start Trial | Warsaw Orthopedic, Inc. (N/A) | 2026-04-13 | RX | search | |
| Genentech | ACTEMRA | tocilizumab | INJECTABLE; INJECTION | 125276 | 001 | 2010-01-08 | Start Trial | Warsaw Orthopedic, Inc. (N/A) | 2039-02-26 | RX | search | |
| Genentech | ACTEMRA | tocilizumab | INJECTABLE; INJECTION | 125276 | 001 | 2010-01-08 | Start Trial | Chelsea Therapeutics, Inc. (Charlotte, NC) | 2024-09-08 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for tocilizumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2019047787 | Start Trial |
| Japan | 2009542721 | Start Trial |
| China | 104159600 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
